These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28040789)

  • 1. Gene expression patterns as predictive biomarkers in hematology-oncology: principal hurdles on the road to the clinic.
    Rázga F; Némethová V
    Haematologica; 2017 Jan; 102(1):e31-e32. PubMed ID: 28040789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in pediatric hematology/oncology.
    Raetz E
    Curr Opin Pediatr; 2017 Feb; 29(1):1-2. PubMed ID: 27870690
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal Hematology and Transfusion Medicine: What We Can Learn from Pediatric Oncology Groups.
    Jain L
    Clin Perinatol; 2015 Sep; 42(3):xv-xvii. PubMed ID: 26250926
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging translational bioinformatics: knowledge-guided biomarker identification for cancer diagnostics.
    Phan JH; Yin-Goen Q; Young AN; Wang MD
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4162-5. PubMed ID: 19964620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematology/Oncology Emergencies.
    Perkins JC; Davis JE
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):xiii-xiv. PubMed ID: 29078935
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
    Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
    [No Abstract]   [Full Text] [Related]  

  • 8. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
    Camp RL; Neumeister V; Rimm DL
    J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 10. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers: the potential of "omics" approach.
    Sikaroodi M; Galachiantz Y; Baranova A
    Curr Mol Med; 2010 Mar; 10(2):249-57. PubMed ID: 20196723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Serial Analysis of Gene Expression in cancer research.
    Yamashita T; Honda M; Kaneko S
    Curr Pharm Biotechnol; 2008 Oct; 9(5):375-82. PubMed ID: 18855690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating predictive biomarkers and classifiers into oncology clinical development programmes.
    Beckman RA; Clark J; Chen C
    Nat Rev Drug Discov; 2011 Sep; 10(10):735-48. PubMed ID: 21959287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and proteomics meet diagnostic hematopathology.
    Carbone A
    Int J Biol Markers; 2002; 17(1):71-2. PubMed ID: 11936591
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of Cancer Gene Profiling Data.
    Roy J; Winter C; Schroeder M
    Methods Mol Biol; 2016; 1381():211-22. PubMed ID: 26667463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel combination approaches for myeloma.
    Lonial S; Nooka AK
    Hematology Am Soc Hematol Educ Program; 2015; 2015():286-93. PubMed ID: 26637735
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology and haematology in 2013. Some advances, but too many new treatments with an inadequately assessed harm-benefit balance.
    Prescrire Int; 2014 Apr; 23(148):103-5. PubMed ID: 24860901
    [No Abstract]   [Full Text] [Related]  

  • 18. Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.
    Marous M; Bièche I; Paoletti X; Alt M; Razak AR; Stathis A; Kamal M; Le Tourneau C
    Ann Oncol; 2015 Dec; 26(12):2419-28. PubMed ID: 26371283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cancer Biotechnology on Diagnostic and Prognostic Indicators in Predictive Oncology and Therapy. Nice, France, October 26-28, 1996. Abstracts.
    Cancer Detect Prev; 1996; 20(5):391-555. PubMed ID: 8951217
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.